Global HER2 Antibodies Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Drugs;

Trastuzumab, Lapatinib, Ado-trastuzumab emtansine, Pertuzumab, and Everolimus.

By Application;

Hospital Pharmacies and Retail Pharmacies.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn101237917 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global HER2 Antibodies Market (USD Million), 2021 - 2031

In the year 2024, the Global HER2 Antibodies Market was valued at USD 9,507.56 million. The size of this market is expected to increase to USD 15,167.46 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.9%.

The Global HER2 Antibodies Market is poised for remarkable growth, fueled by advancements in cancer research and therapeutics. HER2, or human epidermal growth factor receptor 2, is a protein that plays a crucial role in the growth and spread of certain types of cancer, particularly breast cancer. Antibodies targeting HER2 have revolutionized the treatment landscape, offering more effective and targeted therapies for patients. With increasing prevalence of HER2-positive cancers and expanding research into novel antibody-based treatments, the global market for HER2 antibodies is experiencing a surge in demand and innovation.

The development of HER2 antibodies has witnessed significant progress, leading to the introduction of groundbreaking therapies that have transformed patient outcomes. Monoclonal antibodies such as trastuzumab and pertuzumab have become cornerstone treatments in the management of HER2-positive breast cancer, demonstrating remarkable efficacy in both early and advanced stages of the disease. Moreover, ongoing research efforts are focusing on enhancing the therapeutic potential of HER2 antibodies through combination therapies, targeted drug delivery systems, and novel biologics, promising further advancements in cancer treatment.

As the understanding of HER2 biology deepens and technology continues to evolve, the Global HER2 Antibodies Market is expected to witness sustained growth in the coming years. Collaborations between pharmaceutical companies, academic institutions, and research organizations are driving innovation and accelerating the development of next-generation HER2-targeted therapies. Additionally, initiatives aimed at improving access to healthcare and increasing awareness about HER2-positive cancers are contributing to market expansion, particularly in emerging economies. With a growing pipeline of HER2 antibody-based drugs and expanding applications across multiple cancer types, the market holds immense potential for improving patient outcomes and addressing unmet medical needs.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drugs
    2. Market Snapshot, By Application
    3. Market Snapshot, By Region
  4. Global HER2 Antibodies Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing Demand for Personalized Medicine
        2. Strategic Collaborations
        3. Rising Healthcare Expenditure
      2. Restraints
        1. Limited Access in Developing Regions
        2. Patent Expirations
        3. Adverse Effects
      3. Opportunities
        1. Novel Drug Development
        2. Combination Therapies
        3. Patient Education Initiatives
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global HER2 Antibodies Market, By Drugs, 2021 - 2031 (USD Million)
      1. Trastuzumab
      2. Lapatinib
      3. Ado-trastuzumab emtansine
      4. Pertuzumab
      5. Everolimus
    2. Global HER2 Antibodies Market, By Application, 2021 - 2031 (USD Million)
      1. Hospital Pharmacies
      2. Retail Pharmacies
    3. Global HER2 Antibodies Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Novartis AG
      2. Pfizer, Inc.
      3. Genentech Inc. (F. Hoffmann-La Roche Ltd.)
      4. Abnova Corporation
      5. InvivoGen
      6. Celltrion, Inc.
      7. Biocon Limited
      8. Bio-Techne (Novus Biologicals, LLC)
  7. Analyst Views
  8. Future Outlook of the Market